Total Funding
74
50
Total FundingSeries A raised
Growth Score
27 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
66489
A biopharmaceutical company developing novel therapeutic products based on its innovative and patent protected targeted therapeutic system.
- Michael Aldridge: Chief Executive OfficerPast Role: Codexis, Senior Vice President Corporate & Strategic Development
- Anthony Voiers: COOPast Role: Advanced Chemotherapy Technologies, CEO
About the Company
Focal Medical, Inc. is a privately held, biopharmaceutical company developing novel therapeutic products based on its innovative and patent protected targeted therapeutic system. The Company’s lead product is a targeted therapeutic product delivering gemcitabine (an FDA approved chemotherapeutic) actively and directly to the pancreas by
non-circulatory pathways to treat pancreatic cancer. Focal Medical, Inc. is formerly known as Advanced Chemotherapy Technologies, Inc. It is headquartered in Cary, North Carolina.
